Skip to main content
Top
Published in: BMC Primary Care 1/2021

Open Access 01-12-2021 | Cervical Cancer | Research

Barriers and attitudes towards cervical cancer screening in primary healthcare in Poland - doctors’ perspective

Authors: Katarzyna Nessler, Francis Ball, Sze Kay Florence Chan, Michal Chwalek, Anna Krztoń-Królewiecka, Adam Windak

Published in: BMC Primary Care | Issue 1/2021

Login to get access

Abstract

Background

Healthcare systems have adopted different strategies to reduce the burden of cervical cancer. In Poland, a population-based screening program was implemented in 2006, leading to a downward trend in cervical cancer burden. However, screening rates are still low in relation to other EU member states. In Poland, Pap smears are mainly performed by gynecologists rather than Primary Health Care (PHC) physicians. Little is known about the experiences and attitudes of the latter regarding cervical cancer screening in a PHC setting.

Methods

A cross-sectional questionnaire-based survey was carried out among 43 PHC physicians from the Malopolska region in Poland. Barriers and attitudes towards cytology in a PHC setting were evaluated.

Results

Approximately 35% of surveyed physicians reported having experience in performing cytology. Almost 75% of PHC physicians lacked the necessary equipment in their office to perform the screening. None of the studied physicians performed Pap smears in their office at the time. The reasons included: shortage of competence (78.57%) and time (69.05%), the perception of Pap smears as a task for gynecologists (69.05%), the lack of financial incentives (61.90%), and the belief that their patients would be unwilling to undergo the test in their PHC physician’s office (33.33%). More than three quarters (76.74%) declared they would be ready to perform Pap smears if the tests were additionally paid. No significant associations between PHC physicians’ characteristics and their willingness to perform cytology screening were found.

Conclusion

The primary barrier to perform Pap smears by PHC physicians does not lie in their personal reluctance but in the organization of the healthcare system. Provision of required training and proper funding allocation can likely improve the screening rate of cervical cancer in Poland.
Literature
1.
go back to reference Human papillomavirus vaccines: WHO position paper, May 2017. Wkly Epidemiol Rec. 2017 12;92(19):241–68. English, French. Human papillomavirus vaccines: WHO position paper, May 2017. Wkly Epidemiol Rec. 2017 12;92(19):241–68. English, French.
2.
go back to reference Bosch FX, Lorincz A, Muñoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244–65 Review.CrossRef Bosch FX, Lorincz A, Muñoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244–65 Review.CrossRef
3.
go back to reference Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.CrossRef Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.CrossRef
4.
go back to reference de Martel C, Plummer M, Vignat J, et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664–70.CrossRef de Martel C, Plummer M, Vignat J, et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664–70.CrossRef
5.
go back to reference Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRef Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRef
7.
go back to reference Ghebreyesus T. Cervical Cancer: an NCD we can overcome. Speech presented at; 2018; intercontinental hotel, Geneva. Ghebreyesus T. Cervical Cancer: an NCD we can overcome. Speech presented at; 2018; intercontinental hotel, Geneva.
8.
go back to reference European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination. Lawrence von Karsa, Marc Arbyn, Hugo De Vuyst et al. Papillomavirus Research 1 (2015) 22–31. European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination. Lawrence von Karsa, Marc Arbyn, Hugo De Vuyst et al. Papillomavirus Research 1 (2015) 22–31.
9.
go back to reference Nowakowski A, Wojciechowska U, Wieszczy P, et al. Trends in cervical cancer incidence and mortality in Poland: is there an impact of the introduction of the organised screening? Eur J Epidemiol. 2017 Jun;32(6):529–32.CrossRef Nowakowski A, Wojciechowska U, Wieszczy P, et al. Trends in cervical cancer incidence and mortality in Poland: is there an impact of the introduction of the organised screening? Eur J Epidemiol. 2017 Jun;32(6):529–32.CrossRef
10.
go back to reference Nowakowski A, Cybulski M, Śliwczyński A, et al. The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines. BMC Cancer. 2015;15:279.CrossRef Nowakowski A, Cybulski M, Śliwczyński A, et al. The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines. BMC Cancer. 2015;15:279.CrossRef
11.
go back to reference Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, et al. Editors. European guidelines for quality assurance in cervical cancer screening. 2. Luxembourg: Office for Official Publications of the European Communities; 2008. Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, et al. Editors. European guidelines for quality assurance in cervical cancer screening. 2. Luxembourg: Office for Official Publications of the European Communities; 2008.
12.
go back to reference Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, et al. European guidelines for quality assurance in cervical cancer screening: second edition–summary document. Ann Oncol. 2010;21:448–58.CrossRef Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, et al. European guidelines for quality assurance in cervical cancer screening: second edition–summary document. Ann Oncol. 2010;21:448–58.CrossRef
13.
go back to reference Elfström KM, Arnheim-Dahlström L, von Karsa L. Cervical cancer screening in Europe: quality assurance and organisation of programmes. Eur J Cancer. 2015;51(8):950–68.CrossRef Elfström KM, Arnheim-Dahlström L, von Karsa L. Cervical cancer screening in Europe: quality assurance and organisation of programmes. Eur J Cancer. 2015;51(8):950–68.CrossRef
14.
go back to reference Nessler K, Chan SKF. Ball F, et al impact of family physicians on cervical cancer screening: cross-sectional questionnaire-based survey in a region of southern Poland. BMJ Open. 2019;9:e031317.CrossRef Nessler K, Chan SKF. Ball F, et al impact of family physicians on cervical cancer screening: cross-sectional questionnaire-based survey in a region of southern Poland. BMJ Open. 2019;9:e031317.CrossRef
15.
go back to reference Maj C, Poncet L, Panjo H, Gautier A, Chauvin P, Menvielle G, et al. General practitioners who never perform pap smear: the medical offer and the socio-economic context around their office could limit their involvement in cervical cancer screening. BMC Fam Pract. 2019;20(1):114.CrossRef Maj C, Poncet L, Panjo H, Gautier A, Chauvin P, Menvielle G, et al. General practitioners who never perform pap smear: the medical offer and the socio-economic context around their office could limit their involvement in cervical cancer screening. BMC Fam Pract. 2019;20(1):114.CrossRef
16.
go back to reference Favre J, Rochoy M, Raginel T, et al. The effect of cervical smears performed by general practitioners on the cervical Cancer screening rate of their female patients: a claim database analysis and cross-sectional survey. J Women's Health (Larchmt). 2018;27(7):933–8.CrossRef Favre J, Rochoy M, Raginel T, et al. The effect of cervical smears performed by general practitioners on the cervical Cancer screening rate of their female patients: a claim database analysis and cross-sectional survey. J Women's Health (Larchmt). 2018;27(7):933–8.CrossRef
17.
go back to reference Munro A, Pavicic H, Leung Y, et al. The role of general practitioners in the continued success of the National Cervical Screening Program. Aust Fam Physician. 2014;43(5):293–6.PubMed Munro A, Pavicic H, Leung Y, et al. The role of general practitioners in the continued success of the National Cervical Screening Program. Aust Fam Physician. 2014;43(5):293–6.PubMed
18.
go back to reference Khan A, Hussain R, Plummer D, Minichiello V. Willingness to offer chlamydia testing in general practice in New South Wales. Aust N Z J Public Health. 2006;30(3):226–30.CrossRef Khan A, Hussain R, Plummer D, Minichiello V. Willingness to offer chlamydia testing in general practice in New South Wales. Aust N Z J Public Health. 2006;30(3):226–30.CrossRef
19.
go back to reference Poncet L, Rigal L, Panjo H, et al. Disengagement of general practitioners in cervical cancer screening. Eur J Cancer Prev. 2016;25:547–55.CrossRef Poncet L, Rigal L, Panjo H, et al. Disengagement of general practitioners in cervical cancer screening. Eur J Cancer Prev. 2016;25:547–55.CrossRef
20.
go back to reference Rochoy M, Raginel T, Favre J, et al. Factors associated with the achievement of cervical smears by general practitioners. BMC Res Notes. 2017;10:723.CrossRef Rochoy M, Raginel T, Favre J, et al. Factors associated with the achievement of cervical smears by general practitioners. BMC Res Notes. 2017;10:723.CrossRef
21.
go back to reference Neugut AI, MacLean DWF, et al. Physician Characteristics and Decisions Regarding Cancer Screening: A Systematic Review. Popul Health Manag. 2019;22(1):48–62.CrossRef Neugut AI, MacLean DWF, et al. Physician Characteristics and Decisions Regarding Cancer Screening: A Systematic Review. Popul Health Manag. 2019;22(1):48–62.CrossRef
22.
go back to reference Bringedal B, Fretheim A, Nilsen S, Isaksson RK. Do you recommend cancer screening to your patients? A cross-sectional study of Norwegian doctors. BMJ Open. 2019;30:9(8). Bringedal B, Fretheim A, Nilsen S, Isaksson RK. Do you recommend cancer screening to your patients? A cross-sectional study of Norwegian doctors. BMJ Open. 2019;30:9(8).
23.
go back to reference Agurto I, Bishop A, Sanchez G, et al. Perceived barriers and benefits to cervical cancer screening in Latin America. Prev Med. 2004;39(1):91–8.CrossRef Agurto I, Bishop A, Sanchez G, et al. Perceived barriers and benefits to cervical cancer screening in Latin America. Prev Med. 2004;39(1):91–8.CrossRef
24.
go back to reference McDonald P, Herity B, Johnson Z, et al. Views of Irish general practitioners on screening for cervical cancer. Ir J Med Sci. 2001;170(3):186–8.CrossRef McDonald P, Herity B, Johnson Z, et al. Views of Irish general practitioners on screening for cervical cancer. Ir J Med Sci. 2001;170(3):186–8.CrossRef
25.
go back to reference Lin TF, Chen JJ. Effect of Physician Gender on Demand for Pap tests. Economics Research International. 2014; Article ID 647169:1–8. Lin TF, Chen JJ. Effect of Physician Gender on Demand for Pap tests. Economics Research International. 2014; Article ID 647169:1–8.
26.
go back to reference Othman NH, Rebolj M. Challenges to cervical screening in a developing country: the case of Malaysia. Asian Pac J Cancer Prev. 2009;10(5):747–52.PubMed Othman NH, Rebolj M. Challenges to cervical screening in a developing country: the case of Malaysia. Asian Pac J Cancer Prev. 2009;10(5):747–52.PubMed
27.
go back to reference O’Connor M, Murphy J, Martin C, et al. Motivators for women to attend cervical screening: the influential role of GPs. Fam Pract. 2014;31(4):475–82.CrossRef O’Connor M, Murphy J, Martin C, et al. Motivators for women to attend cervical screening: the influential role of GPs. Fam Pract. 2014;31(4):475–82.CrossRef
28.
go back to reference Wong LP, Wong YL, Low WY, et al. Cervical cancer screening attitudes and beliefs of Malaysian women who have never had a pap smear: a qualitative study. Int J Behav Med. 2008;15(4):289–92.CrossRef Wong LP, Wong YL, Low WY, et al. Cervical cancer screening attitudes and beliefs of Malaysian women who have never had a pap smear: a qualitative study. Int J Behav Med. 2008;15(4):289–92.CrossRef
29.
go back to reference McFarland DM. Cervical cancer and pap smear screening in Botswana: knowledge and perceptions. Int Nurse Rev. 2003;50(3):167–75.CrossRef McFarland DM. Cervical cancer and pap smear screening in Botswana: knowledge and perceptions. Int Nurse Rev. 2003;50(3):167–75.CrossRef
30.
go back to reference Lee J, Seow A, Ling SL, et al. Improving adherence to regular pap smear screening among Asian women: a population-based study in Singapore. Health Educ Behav. 2002;29(2):207–18.CrossRef Lee J, Seow A, Ling SL, et al. Improving adherence to regular pap smear screening among Asian women: a population-based study in Singapore. Health Educ Behav. 2002;29(2):207–18.CrossRef
31.
go back to reference Anttila A, Nieminen P. Cervical cancer screening programme in Finland with an example on implementing alternative screening methods. Coll Antropol. 2007;31(Suppl 2):17–22.PubMed Anttila A, Nieminen P. Cervical cancer screening programme in Finland with an example on implementing alternative screening methods. Coll Antropol. 2007;31(Suppl 2):17–22.PubMed
Metadata
Title
Barriers and attitudes towards cervical cancer screening in primary healthcare in Poland - doctors’ perspective
Authors
Katarzyna Nessler
Francis Ball
Sze Kay Florence Chan
Michal Chwalek
Anna Krztoń-Królewiecka
Adam Windak
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Primary Care / Issue 1/2021
Electronic ISSN: 2731-4553
DOI
https://doi.org/10.1186/s12875-021-01612-8

Other articles of this Issue 1/2021

BMC Primary Care 1/2021 Go to the issue